glp-1/gip vs tirzepatide Beyond glycemia: Comparing to GLP-1 analogues | Reviews in Endocrine and Metabolic Disorders xmlinkhub

doi: 10.1002/hep.26672

This process is supported by regular checks and monitoring

But she wanted to get her diabetes under control, so started taking it in 2021

Demographic Groups Leading GLP-1 Weight Loss Medication Growth Women comprise approximately 65 percent of GLP-1 medication users, reflecting higher engagement with weight management and willingness to pursue pharmacologic interventions alongside lifestyle changes

Additionally, the use of TriNetX for this study was approved by the Institutional Review Board of Chi-Mei Hospital (No: 11210-E01)

Since both medications belong to the same class (GLP-1), they work in similar ways, but switching may require adjustments to your dosage and monitoring for potential side effects as your body adjusts